MS
ABMD

Mizuho Securities’s Abiomed Inc ABMD Stock Holding History

Mizuho Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-140
Closed -$45K – 202
2020
Q4 		$45K Buy
+140
New +$38.7K 0.01% 61
2020
Q3 		– Sell
-480
Closed -$70K – 94
2020
Q2 		$70K Buy
+480
New +$96.4K 0.02% 51
2020
Q1 		– Sell
-200
Closed -$34K – 137
2019
Q4 		$34K Sell
200
-560
-74% -$104K 0.02% 123
2019
Q3 		$135K Sell
760
-30
-4% -$6.49K 0.09% 62
2019
Q2 		$206K Sell
790
-1,090
-58% -$289K 0.27% 45
2019
Q1 		$537K Buy
1,880
+1,490
+382% +$495K 1.17% 21
2018
Q4 		$127K Buy
+390
New +$135K 0.01% 29

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mizuho Securities's ABMD Position: Q1 2021 in Review

Mizuho Securities sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 140 shares — an estimated $45K sold.

Mizuho Securities first reported a position in ABMD in Q4 2018 and held it in 7 quarters. The position peaked at $537K in Q1 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Mizuho Securities reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Mizuho Securities sold 140 Abiomed Inc shares in Q1 2021, an estimated $45K.
  • Mizuho Securities first reported a position in Abiomed Inc in Q4 2018 and held it in 7 quarters.
  • Mizuho Securities's Abiomed Inc position peaked at $537K in Q1 2019.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Mizuho Securities's 13F filing for Q1 2021, filed 14 May 2021.